صدى البلد البلد سبورت قناة صدى البلد صدى البلد جامعات صدى البلد عقارات
Supervisor Elham AbolFateh
Editor in Chief Mohamed Wadie

US: Officials Investigate Death of Healthcare Worker after Pfizer Vaccination


Fri 29 Jan 2021 | 08:15 PM
Ahmed Moamar

Officials in Orange County, California, are investigating the death of a 60-year-old healthcare worker who died four days after receiving his second injection of the Pfizer-BioNTech COVID-19. vaccine, as Life Site reported.

The wife of Tim Zook, a 60-year-old x-ray technician who became seriously ill hours after getting his second Pfizer vaccine and died four days later, says 'we need to know the cause."

Zook, an x-ray technologist at South Coast Global Medical Center in Santa Ana, was hospitalized on Jan. 5, several hours after being vaccinated.

Zook’s wife, Rochelle Zook, told the Orange County Register that her husband’s health rapidly deteriorated over the next few days. He died Jan. 9.

Rochelle Zook said her husband believed in vaccines, and that she didn’t blame “any pharmaceutical company” for his death.

She also said: “But when someone gets symptoms 2 1/2 hours after a vaccine, that’s a reaction.

What else could have happened? We would like the public to know what happened to Tim, so he didn’t die in vain.

Severe reactions are rare. In reality, COVID is a much more deadly force than reactions from the potential vaccine itself.

“The message is, be safe, take the vaccine — but the officials need to do more research. We need to know the cause. The vaccines need to be as safe as possible. Every life matters."

Tim Zook was “quite healthy” his wife said, though he took medication for high blood pressure and was slightly overweight.

“He had never been hospitalized. He’d get a cold and be over it two days later. The flu, and be over it three days later.”

In an email to the Orange County Register, Pfizer said it was aware of Zook’s death: “We closely monitor all such events and collect relevant information to share with global regulatory authorities. Based on ongoing safety reviews performed by Pfizer, BioNTech and health authorities, (the vaccine) retains a positive benefit-risk profile for the prevention of COVID-19 infections."